Dothiepin hydrochloride and Jme - a phase IV clinical study of FDA data
We study 1,509 people who take Dothiepin hydrochloride or have Jme. No report of Jme is found in people who take Dothiepin hydrochloride.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Dothiepin Hydrochloride?
Dothiepin hydrochloride has active ingredients of dothiepin hydrochloride. It is often used in depression. eHealthMe is studying from 809 Dothiepin hydrochloride users for its effectiveness, alternative drugs and more.
What is Jme?
Jme is found to be associated with 97 drugs and 58 conditions by eHealthMe.
Do you take Dothiepin hydrochloride and have Jme?Check whether Jme is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Jme and when was it recovered:
Expand to all the drugs that have ingredients of dothiepin hydrochloride:
Alternative drugs to, pros and cons of Dothiepin hydrochloride:
- Dothiepin hydrochloride (809 reports)
Jme treatments and more:
- Jme (700 reports)
COVID vaccines that are related to Jme:
- Jme in Moderna COVID Vaccine
- Jme in Pfizer BioNTech Covid Vaccine
- Jme in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Jme:
All the conditions that are associated with Jme:
How the study uses the data?
The study uses data from the FDA. It is based on dothiepin hydrochloride (the active ingredients of Dothiepin hydrochloride) and Dothiepin hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tadalafil and Eye Movements - Uncontrollable - 5 seconds ago
- Unisom and Zyloprim drug interaction - 6 seconds ago
- Clonidine and Tachypnea - 7 seconds ago
- Furuncle and drugs of ingredients of topiramate - 9 seconds ago
- Cubicin and Coagulation Factor V Level Decreased - 12 seconds ago
- Slo-Niacin and Timoptic drug interaction - 12 seconds ago
- Guaifenesin and Vitamin B12 Deficiency - 19 seconds ago
- Selenium and Urticaria - 20 seconds ago
- Mitomycin and Clostridium Difficile Colitis - 20 seconds ago
- Seroquel and Nausea And Vomiting - 26 seconds ago